DOCSLIB.ORG

Oxygenase 1 Agonists

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Oxygenase 1 Agonists Inhibition of Inducible Nitric Oxide Synthase by Peroxisome Proliferator-Activated Receptor Agonists: Correlation with Induction of Heme Oxygenase 1 This information is current as of September 24, 2021. Paul R. Colville-Nash, Saima S. Qureshi, Dean Willis and Derek A. Willoughby J Immunol 1998; 161:978-984; ; http://www.jimmunol.org/content/161/2/978 Downloaded from References This article cites 37 articles, 13 of which you can access for free at: http://www.jimmunol.org/content/161/2/978.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Inhibition of Inducible Nitric Oxide Synthase by Peroxisome Proliferator-Activated Receptor Agonists: Correlation with Induction of Heme Oxygenase 11 Paul R. Colville-Nash, Saima S. Qureshi, Dean Willis,2 and Derek A. Willoughby Genetic knock-out in mice of peroxisome proliferator-activated receptor-a (PPARa) can prolong inflammation in response to leukotriene B4. Although cyclooxygenase 2 has been shown to be induced by PPAR activation, the effect of PPAR agonists on the key inflammatory enzyme systems of nitric oxide synthase (NOS) and stress proteins has not been investigated. The effect on these a of naturally occurring eicosanoid PPAR agonists (leukotriene B4 and 8(S)-hydroxyeicosatetraenoic acid, which are PPAR se- D12 g a lective; PGA2, PGD2, PGJ2, and PGJ2, which are PPAR selective) and the synthetic PPAR agonist Wy14,643 was examined Downloaded from in activated RAW264.7 murine macrophages. Leukotriene B4 and 8(S)-hydroxyeicosatetraenoic acid stimulated nitrite accumu- D12 lation, indicative of enhanced NOS activity. PGA2, PGD2, PGJ2, PGJ2, and Wy14,643 reduced nitrite accumulation, with D12 PGJ2 being the most effective. The mechanism behind this reduction was examined using Western blotting. Inhibition of nitrite accumulation was associated with a fall in inducible NOS protein and an induction of heme oxygenase 1, correlating both dose dependently and temporally. Other proteins examined (cyclooxygenase 2, heme oxygenase 2, heat shock protein 70, and glucose- regulated protein 78) were unaffected. The data suggest that naturally occurring PPAR agonists can inhibit the inducible NOS enzyme pathway. This inhibition may be mediated by modulation of the stress protein, heme oxygenase 1. Thus, the generation http://www.jimmunol.org/ of eicosanoid breakdown products during inflammation may contribute to its eventual resolution by activation of the PPAR system. This system may thus represent a novel target for therapeutic intervention in inflammatory disease. The Journal of Immunology, 1998, 161: 978–984. he inflammatory response involves the sequential activa- One subclass of PGs, the cyclopentenone PGs, has been shown tion of a number of signaling pathways, resulting in the to cause a variety of biologic effects, including cessation of cell T production of a variety of mediators that act both locally growth (5) and induction of cell differentiation (6). This has im- and systemically. Since the demonstration that part of the anti- plications for a variety of diseases, such as tumorigenesis and de- by guest on September 24, 2021 inflammatory activity of aspirin stems from inhibition of cycloox- fects in lipid physiology. In the latter field, it has been demon- ygenase (COX)3 (1) and a reduction in the formation of PG, there strated that the cyclopentenone PGs are among the endogenous have been enormous advances in the understanding of this path- activators of a class of nuclear receptors, the peroxisome prolif- way, as well as the discovery of a role for a variety of other path- erator-activated receptors (PPARs; for a review, see Refs. 7 and 8). ways in inflammation, such as nitric oxide synthase (NOS; partic- These were originally discovered from work with early hypolipi- ularly the inducible isoform (iNOS) (2)) and nitric oxide (NO), the demic drugs such as the fibrates. Ligands for these receptors in- stress proteins (heat shock proteins (HSPs)) (3), and the heme ox- clude a variety of other drugs such as the antidiabetic thiazo- ygenase (HO) (4) pathway. Much interest is now focused on the lidinediones, xenobiotics, certain members of the eicosanoid interactions between these systems, their potential role in modu- pathways such as the leukotrienes (LT), and fatty acids. Three lating inflammation, and their role as therapeutic targets for inter- subtypes have been described to date, PPARa, PPARb (also re- vention in inflammation and other forms of disease. lated to PPARd, murine fatty acid-activated receptor, and NUC1) and PPARg. Their activation leads to the induction of a variety of genes such as those coding for the enzymes for b- and v-oxidation Department of Experimental Pathology, St. Bartholomew’s and The Royal London of fatty acids (9), transferrin (10), and transthyretin (11). In addi- School of Medicine and Dentistry, London, United Kingdom tion to this information, it is known that cyclopentenone PGs are Received for publication November 12, 1997. Accepted for publication March capable of modifying the stress response by activation of heat 23, 1998. shock factor 1 (HSF-1 (5)) and induction of HSP70 (12) and HO-1 The costs of publication of this article were defrayed in part by the payment of page (13), which have been implicated in the biologic actions of this charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. class of PGs. Whether this is mediated via the PPARs is at present 1 P.R.C.-N. was the recipient of a fellowship sponsored by the Hyal Research Foun- unclear, but it has been demonstrated that PPARs are associated dation, Canada. D.W. was supported by ONO Pharmaceutical Co. Ltd., Japan. with HSP72 (14), and it has been hypothesized that this association 2 Address correspondence and reprint requests to Dr D. Willis, Department of Ex- may be important in the signaling pathways of these receptors. perimental Pathology, St. Bartholomew’s and The Royal London School of Medicine Recently, it has been demonstrated that the inflammatory re- and Dentistry, Charterhouse Square, London, EC1 M 6BQ, U.K. E-mail address: [email protected] sponse to leukotriene B4 (LTB4) is prolonged in genetically modified mice with homozygous knock-out of PPARa (15). 3 Abbreviations used in this paper: COX, cyclooxygenase; NOS, nitric oxide syn- thase; iNOS, inducible nitric oxide synthase; NO, nitric oxide; HSP, heat shock pro- Devchand et al. (15) proposed that, in wild-type mice, LTB4 teins; HO, heme oxygenase; PPAR, peroxisome proliferator-activated receptor; HSF, would activate PPARa, induce fatty acid oxidation pathways, heat shock factor; LTB4, leukotriene B4; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-di- phenyl-tetrazolium; GRP78, glucose-regulated protein 78; 8(S)-HETE, 8 hydroxy- which in turn would degrade lipid mediators of inflammation, 5,9,11,14-eicosatetraenoic acid; ZnDPP, zinc deuteroprotoporphyrin. and concluded that activators of PPARa should be Copyright © 1998 by The American Association of Immunologists 0022-1767/98/$02.00 The Journal of Immunology 979 anti-inflammatory. However, this enhanced degradation of lipid U.K.). Anti-rabbit IgG for ECL (Amersham) was used at dilutions of mediators has not been demonstrated in this model, and a va- 1:2000 for HO-1, HO-2, and GRP78, 1:3000 for COX-2, and 1:4000 for riety of other inflammatory mechanisms such as those suggested iNOS and HSP70. Bands were recorded on x-ray film (Fuji RX, Genetic Research Instrumentation, Dunmow, U.K.) for permanent record. Repre- above may also be important in the effects attributable to PPAR sentative blots from three experiments are presented. activation. To date, the effect of cyclopentenone PGs and other PPAR ago- Statistical analysis nists on iNOS in macrophages, a key cell and enzyme system in Results are representative of three experiments with n 5 6 in each group. inflammation and other pathologies, has not been described. In this Significance of data was examined by analysis of variance (ANOVA) fol- D12 g lowed by a post hoc Bonferroni-corrected t test (Instat, GraphPad Software, study, we demonstrate that PGJ2, a PPAR agonist, is a potent inhibitor of iNOS activity and protein expression in stimulated University of Amsterdam, The Netherlands). RAW264.7 macrophages. Protein expression and inhibitor studies Results implicate activation of HO-1 in this phenomenon. Effects of various PPAR agonists on viability and iNOS activity Materials and Methods in stimulated RAW264.7 macrophages Culture and stimulation of murine RAW264.7 macrophages Stimulation of macrophages with IFN-g and LPS routinely in- creased nitrite levels in medium by .12-fold after 18 h, compared RAW264.7 macrophages (European Collection of Animal Cell Cultures) were cultured as described previously (16). Cells were passaged and grown with nonstimulated cultures (data not shown). Viability of cell cul- m to 90% confluence in 96-well plates (Greiner) for analysis of nitrite pro- tures (Fig. 1) treated with up to 10 g/ml of LTB4,8(S)-hydroxy- duction and viability or in 75-cm2 culture flasks (Greiner, Stonehouse, Downloaded from eicosatetraenoic acid (8(S)-HETE), PGA2, PGD2, and PGJ2 was U.K.) for Western blot analysis of protein expression.
Load more

Recommended publications
  • Table 2. Functional Classification of Genes Differentially Regulated After HOXB4 Inactivation in HSC/Hpcs
    Table 2. Functional classification of genes differentially regulated after HOXB4 inactivation in HSC/HPCs Symbol Gene description Fold-change (mean ± SD) Signal transduction Adam8 A disintegrin and metalloprotease domain 8 1.91 ± 0.51 Arl4 ADP-ribosylation factor-like 4 - 1.80 ± 0.40 Dusp6 Dual specificity phosphatase 6 (Mkp3) - 2.30 ± 0.46 Ksr1 Kinase suppressor of ras 1 1.92 ± 0.42 Lyst Lysosomal trafficking regulator 1.89 ± 0.34 Mapk1ip1 Mitogen activated protein kinase 1 interacting protein 1 1.84 ± 0.22 Narf* Nuclear prelamin A recognition factor 2.12 ± 0.04 Plekha2 Pleckstrin homology domain-containing. family A. (phosphoinosite 2.15 ± 0.22 binding specific) member 2 Ptp4a2 Protein tyrosine phosphatase 4a2 - 2.04 ± 0.94 Rasa2* RAS p21 activator protein 2 - 2.80 ± 0.13 Rassf4 RAS association (RalGDS/AF-6) domain family 4 3.44 ± 2.56 Rgs18 Regulator of G-protein signaling - 1.93 ± 0.57 Rrad Ras-related associated with diabetes 1.81 ± 0.73 Sh3kbp1 SH3 domain kinase bindings protein 1 - 2.19 ± 0.53 Senp2 SUMO/sentrin specific protease 2 - 1.97 ± 0.49 Socs2 Suppressor of cytokine signaling 2 - 2.82 ± 0.85 Socs5 Suppressor of cytokine signaling 5 2.13 ± 0.08 Socs6 Suppressor of cytokine signaling 6 - 2.18 ± 0.38 Spry1 Sprouty 1 - 2.69 ± 0.19 Sos1 Son of sevenless homolog 1 (Drosophila) 2.16 ± 0.71 Ywhag 3-monooxygenase/tryptophan 5- monooxygenase activation protein. - 2.37 ± 1.42 gamma polypeptide Zfyve21 Zinc finger. FYVE domain containing 21 1.93 ± 0.57 Ligands and receptors Bambi BMP and activin membrane-bound inhibitor - 2.94 ± 0.62
    [Show full text]
  • Carbon Monoxide Prevents TNF-Α-Induced Enos Downregulation by Inhibiting NF-Κb-Responsive Mir-155-5P Biogenesis
    OPEN Experimental & Molecular Medicine (2017) 49, e403; doi:10.1038/emm.2017.193 Official journal of the Korean Society for Biochemistry and Molecular Biology www.nature.com/emm ORIGINAL ARTICLE Carbon monoxide prevents TNF-α-induced eNOS downregulation by inhibiting NF-κB-responsive miR-155-5p biogenesis Seunghwan Choi1, Joohwan Kim1, Ji-Hee Kim1, Dong-Keon Lee1, Wonjin Park1, Minsik Park1, Suji Kim1, Jong Yun Hwang2, Moo-Ho Won3, Yoon Kyung Choi1,4, Sungwoo Ryoo5, Kwon-Soo Ha1, Young-Guen Kwon6 and Young-Myeong Kim1 Heme oxygenase-1-derived carbon monoxide prevents inflammatory vascular disorders. To date, there is no clear evidence that HO-1/CO prevents endothelial dysfunction associated with the downregulation of endothelial NO synthesis in human endothelial cells stimulated with TNF-α. Here, we found that the CO-releasing compound CORM-2 prevented TNF-α-mediated decreases in eNOS expression and NO/cGMP production, without affecting eNOS promoter activity, by maintaining the functional activity of the eNOS mRNA 3′-untranslated region. By contrast, CORM-2 inhibited MIR155HG expression and miR-155-5p biogenesis in TNF-α-stimulated endothelial cells, resulting in recovery of the 3′-UTR activity of eNOS mRNA, a target of miR-155-5p. The beneficial effect of CORM-2 was blocked by an NF-κB inhibitor, a miR-155-5p mimic, a HO-1 inhibitor and siRNA against HO-1, indicating that CO rescues TNF-α-induced eNOS downregulation through NF-κB-responsive miR-155-5p expression via HO-1 induction; similar protective effects of ectopic HO-1 expression and bilirubin were observed in endothelial cells treated with TNF-α.
    [Show full text]
  • Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease
    antioxidants Review Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease Heather A. Drummond 1, Zachary L. Mitchell 1, Nader G. Abraham 2,3 and David E. Stec 1,* 1 Department of Physiology and Biophysics, Mississippi Center for Obesity Research, University of Mississippi Medical Center, Jackson, MI 39216, USA; [email protected] (H.A.D.); [email protected] (Z.L.M.) 2 Departments of Medicine and Pharmacology, New York Medical College, Vahalla, NY 10595, USA; [email protected] 3 Joan C. Edwards School of Medicine, Marshall University, Huntington, VA 25701, USA * Correspondence: [email protected]; Tel.: +1-601-815-1859; Fax: +1-601-984-1817 Received: 3 June 2019; Accepted: 15 June 2019; Published: 18 June 2019 Abstract: Heme oxygenase (HO) plays an important role in the cardiovascular system. It is involved in many physiological and pathophysiological processes in all organs of the cardiovascular system. From the regulation of blood pressure and blood flow to the adaptive response to end-organ injury, HO plays a critical role in the ability of the cardiovascular system to respond and adapt to changes in homeostasis. There have been great advances in our understanding of the role of HO in the regulation of blood pressure and target organ injury in the last decade. Results from these studies demonstrate that targeting of the HO system could provide novel therapeutic opportunities for the treatment of several cardiovascular and renal diseases. The goal of this review is to highlight the important role of HO in the regulation of cardiovascular and renal function and protection from disease and to highlight areas in which targeting of the HO system needs to be translated to help benefit patient populations.
    [Show full text]
  • Relating Metatranscriptomic Profiles to the Micropollutant
    1 Relating Metatranscriptomic Profiles to the 2 Micropollutant Biotransformation Potential of 3 Complex Microbial Communities 4 5 Supporting Information 6 7 Stefan Achermann,1,2 Cresten B. Mansfeldt,1 Marcel Müller,1,3 David R. Johnson,1 Kathrin 8 Fenner*,1,2,4 9 1Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, 10 Switzerland. 2Institute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 11 Zürich, Switzerland. 3Institute of Atmospheric and Climate Science, ETH Zürich, 8092 12 Zürich, Switzerland. 4Department of Chemistry, University of Zürich, 8057 Zürich, 13 Switzerland. 14 *Corresponding author (email: [email protected] ) 15 S.A and C.B.M contributed equally to this work. 16 17 18 19 20 21 This supporting information (SI) is organized in 4 sections (S1-S4) with a total of 10 pages and 22 comprises 7 figures (Figure S1-S7) and 4 tables (Table S1-S4). 23 24 25 S1 26 S1 Data normalization 27 28 29 30 Figure S1. Relative fractions of gene transcripts originating from eukaryotes and bacteria. 31 32 33 Table S1. Relative standard deviation (RSD) for commonly used reference genes across all 34 samples (n=12). EC number mean fraction bacteria (%) RSD (%) RSD bacteria (%) RSD eukaryotes (%) 2.7.7.6 (RNAP) 80 16 6 nda 5.99.1.2 (DNA topoisomerase) 90 11 9 nda 5.99.1.3 (DNA gyrase) 92 16 10 nda 1.2.1.12 (GAPDH) 37 39 6 32 35 and indicates not determined. 36 37 38 39 S2 40 S2 Nitrile hydration 41 42 43 44 Figure S2: Pearson correlation coefficients r for rate constants of bromoxynil and acetamiprid with 45 gene transcripts of ECs describing nucleophilic reactions of water with nitriles.
    [Show full text]
  • Flavin-Containing Monooxygenases: Regulation, Endogenous Roles and Dietary Supplements
    Flavin-containing monooxygenases: Regulation, endogenous roles and dietary supplements A thesis submitted to the University of London in partial fulfilment of the requirements for the degree of Doctor of Philosophy by Lyndsey Houseman Department of Biochemistry and Molecular Biology University College London February 2008 1, Lyndsey Houseman, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. 1 UMI Number: U59122B All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Dissertation Publishing UMI U591223 Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Abstract To investigate the regulation of flavin-containing monooxygenase 5 (FM05) by xenobiotics in mouse liver, a method for isolating primary mouse hepatocytes was designed. Fmo5 expression was up-regulated by hormones (estradiol, progesterone), dietary supplements (lipoic acid) and other xenobiotics (rifampicin, ethanol) in primary mouse hepatocytes and HepG2 cells. Gene reporter assays showed that Fmo5 expression in HepG2 cells is mediated by pregnane-x-receptor (PXR) ligands. To uncover more about the endogenous role of FMOs, two knockout mouse models, Fmol, 2, 4 (-/-) and Fmo5 (-/-), were studied.
    [Show full text]
  • Mechanistic Study of Cysteine Dioxygenase, a Non-Heme
    MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE, A NON-HEME MONONUCLEAR IRON ENZYME by WEI LI Presented to the Faculty of the Graduate School of The University of Texas at Arlington in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY THE UNIVERSITY OF TEXAS AT ARLINGTON August 2014 Copyright © by Student Name Wei Li All Rights Reserved Acknowledgements I would like to thank Dr. Pierce for your mentoring, guidance and patience over the five years. I cannot go all the way through this without your help. Your intelligence and determination has been and will always be an example for me. I would like to thank my committee members Dr. Dias, Dr. Heo and Dr. Jonhson- Winters for the directions and invaluable advice. I also would like to thank all my lab mates, Josh, Bishnu ,Andra, Priyanka, Eleanor, you all helped me so I could finish my projects. I would like to thank the Department of Chemistry and Biochemistry for the help with my academic and career. At Last, I would like to thank my lovely wife and beautiful daughter who made my life meaningful and full of joy. July 11, 2014 iii Abstract MECHANISTIC STUDY OF CYSTEINE DIOXYGENASE A NON-HEME MONONUCLEAR IRON ENZYME Wei Li, PhD The University of Texas at Arlington, 2014 Supervising Professor: Brad Pierce Cysteine dioxygenase (CDO) is an non-heme mononuclear iron enzymes that catalyzes the O2-dependent oxidation of L-cysteine (Cys) to produce cysteine sulfinic acid (CSA). CDO controls cysteine levels in cells and is a potential drug target for some diseases such as Parkinson’s and Alzhermer’s.
    [Show full text]
  • FMO3) As a Novel Genetic Determinant of Acetaminophen (APAP) Induced Hepatotoxicity Swetha Rudraiah University of Connecticut - Storrs, [email protected]
    University of Connecticut OpenCommons@UConn Doctoral Dissertations University of Connecticut Graduate School 8-4-2014 Characterization of Flavin-containing Monooxygenase-3 (FMO3) as a Novel Genetic Determinant of Acetaminophen (APAP) Induced Hepatotoxicity Swetha Rudraiah University of Connecticut - Storrs, [email protected] Follow this and additional works at: https://opencommons.uconn.edu/dissertations Recommended Citation Rudraiah, Swetha, "Characterization of Flavin-containing Monooxygenase-3 (FMO3) as a Novel Genetic Determinant of Acetaminophen (APAP) Induced Hepatotoxicity" (2014). Doctoral Dissertations. 506. https://opencommons.uconn.edu/dissertations/506 Characterization of Flavin-containing Monooxygenase-3 (FMO3) as a Novel Genetic Determinant of Acetaminophen (APAP) Induced Hepatotoxicity Swetha Rudraiah, Ph.D. University of Connecticut, 2014 Mice pretreated with a mild toxic dose of acetaminophen (APAP) acquire resistance to a second, higher APAP dose. This phenomenon is termed APAP autoprotection and the exact mechanism by which such resistance develops is not clearly known. Given the prevalence of APAP- hepatotoxicity and the human health impact of this potentially hepatotoxic agent, a further understanding of the mechanism(s) involved in such protection are of considerable significance and could lead to new modalities of treatment of acute drug-induced liver injury. The work presented in this thesis investigates FMO3 gene expression during APAP-induced liver injury as well as the functional significance of FMO3 over-expression during APAP- induced liver injury. Furthermore, FMO3 gene regulation during oxidative stress conditions is also examined. Acetaminophen treatment resulted in up-regulation of liver Fmo3 protein in male mice. Female mice express higher liver Fmo3 than males and are highly resistant to APAP hepatotoxicity.
    [Show full text]
  • Adrenocorticotropin Induces Heme Oxygenase-1 Expression in Adrenal Cells
    113 Adrenocorticotropin induces heme oxygenase-1 expression in adrenal cells Y Pomeraniec, N Grion, L Gadda, V Pannunzio, E J Podesta and C B Cymeryng Departamento de Bioquí mica Humana, Facultad de Medicina, Universidad de Buenos Aires, Paraguay 2155, 5 piso, C1121 ABG, Buenos Aires, Argentina (Requests for offprints should be addressed to C B Cymeryng; Email: [email protected]) Abstract Heme oxygenase (HO) catalyzes the first and rate- and cycloheximide completely blocked the effect of controlling step of heme catabolism into biliverdin, iron ACTH on HO-1 mRNA expression whereas mRNA and carbon monoxide. Three isoforms of HO have been stability was not affected by ACTH. Permeable analogs identified so far: the inducible HO-1 and the constitutive of cAMP mimicked the effect of ACTH on HO-1 HO-2 and HO-3. Both HO-1 and HO-2 were expressed expression and ACTH induction was prevented by the in zona fasciculata (ZF) adrenal cells and in a mouse protein kinase A (PKA) inhibitor H89. Steroid production adrenocortical cell line (Y1). HO-1 but not HO-2 was significantly increased when both HO-1 and HO-2 expression was upregulated by adrenocorticotropic hor- activities were inhibited by Sn-protoporphyrin IX mone (ACTH) and accumulation of HO-1 protein corre- (SnPPIX). The lipid peroxidation and increase in carbonyl lated with an increase in HO activity in Y1 cells. ACTH content triggered by hydrogen peroxide was prevented by induced HO-1 expression in a time- and dose-dependent treatment of Y1 cells with bilirubin and ACTH. manner with a maximum after 5 h of treatment and a Journal of Endocrinology (2004) 180, 113–124 threshold concentration of 0·1 mIU/ml.
    [Show full text]
  • The Blockade of Cyclooxygenases-1 and -2 Reduces the Effects of Hypoxia on Endothelial Cells
    Brazilian Journal of Medical and Biological Research (2006) 39: 1189-1196 Endothelial cell activation and hypoxia 1189 ISSN 0100-879X The blockade of cyclooxygenases-1 and -2 reduces the effects of hypoxia on endothelial cells M.A. Gloria1, 1Laboratório de Imunologia Clínica e Experimental, Divisão de Nefrologia, M.A. Cenedeze1, Universidade Federal de São Paulo, Hospital do Rim e Hipertensão, A. Pacheco-Silva1 Fundação Oswaldo Ramos, São Paulo, SP, Brasil and N.O.S. Câmara1,2 2Laboratório de Imunobiologia de Transplantes, Departamento de Imunologia, Instituto de Ciências Biomédicas IV, Universidade de São Paulo, São Paulo, SP, Brasil Abstract Correspondence Hypoxia activates endothelial cells by the action of reactive oxygen Key words N.O.S. Câmara species generated in part by cyclooxygenases (COX) production • Endothelial cell Laboratório de Imunologia Clínica enhancing leukocyte transmigration. We investigated the effect of • Hypoxia e Experimental specific COX inhibition on the function of endothelial cells exposed • Indomethacin Divisão de Nefrologia, UNIFESP to hypoxia. Mouse immortalized endothelial cells were subjected to • Cyclooxygenase Rua Botucatu, 740 • Heme oxygenase 1 04023-900 São Paulo, SP 30 min of oxygen deprivation by gas exchange. Acridine orange/ Brasil ethidium bromide dyes and lactate dehydrogenase activity were used Fax: +55-11-5573-9652 to monitor cell viability. The mRNA of COX-1 and -2 was amplified E-mail: [email protected] and semi-quantified before and after hypoxia in cells treated or not with indomethacin, a non-selective COX inhibitor. Expression of Research supported by CAPES and RANTES (regulated upon activation, normal T cell expressed and FAPESP (Nos. 04/08311-6 and secreted) protein and the protective role of heme oxygenase-1 (HO-1) 04/13826-5).
    [Show full text]
  • Significance of Heme and Heme Degradation in the Pathogenesis Of
    International Journal of Molecular Sciences Review Significance of Heme and Heme Degradation in the Pathogenesis of Acute Lung and Inflammatory Disorders Stefan W. Ryter Proterris, Inc., Boston, MA 02118, USA; [email protected] Abstract: The heme molecule serves as an essential prosthetic group for oxygen transport and storage proteins, as well for cellular metabolic enzyme activities, including those involved in mitochondrial respiration, xenobiotic metabolism, and antioxidant responses. Dysfunction in both heme synthesis and degradation pathways can promote human disease. Heme is a pro-oxidant via iron catalysis that can induce cytotoxicity and injury to the vascular endothelium. Additionally, heme can modulate inflammatory and immune system functions. Thus, the synthesis, utilization and turnover of heme are by necessity tightly regulated. The microsomal heme oxygenase (HO) system degrades heme to carbon monoxide (CO), iron, and biliverdin-IXα, that latter which is converted to bilirubin-IXα by biliverdin reductase. Heme degradation by heme oxygenase-1 (HO-1) is linked to cytoprotection via heme removal, as well as by activity-dependent end-product generation (i.e., bile pigments and CO), and other potential mechanisms. Therapeutic strategies targeting the heme/HO-1 pathway, including therapeutic modulation of heme levels, elevation (or inhibition) of HO-1 protein and activity, and application of CO donor compounds or gas show potential in inflammatory conditions including sepsis and pulmonary diseases. Keywords: acute lung injury; carbon monoxide; heme; heme oxygenase; inflammation; lung dis- ease; sepsis Citation: Ryter, S.W. Significance of Heme and Heme Degradation in the Pathogenesis of Acute Lung and Inflammatory Disorders. Int. J. Mol. 1. Introduction Sci.
    [Show full text]
  • Heme Oxygenase-1 Affects Cytochrome P450 Function Through the Formation of Heteromeric Complexes: Interactions Between CYP1A2 and Heme Oxygenase-1
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.14.296467; this version posted September 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Heme oxygenase-1 affects cytochrome P450 function through the formation of heteromeric complexes: Interactions between CYP1A2 and heme oxygenase-1 J. Patrick Connick, James R. Reed, George F. Cawley, and Wayne L. Backes* Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center – New Orleans, LA *Corresponding author: Wayne L. Backes E-mail: [email protected] Running title: Interactions between CYP1A2 and HO-1 Keywords: Cytochrome P450, heme oxygenase, protein-protein interaction, bioluminescence resonance energy transfer (BRET), membrane protein, structure-function, electron transfer, NADPH-cytochrome P450 reductase, CYP1A2 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.14.296467; this version posted September 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract can be “uncoupled,” leading to generation of superoxide and H2O2 (4). Heme oxygenase 1 (HO-1) and the cytochromes P450 (P450s) are endoplasmic reticulum-bound HO-1 is responsible for the first step of heme enzymes that rely on the same protein, NADPH- degradation, converting the substrate to biliverdin cytochrome P450 reductase (POR), to provide the (5,6). This enzyme protects cells from oxidative electrons necessary for substrate metabolism. damage, and is induced by agents that are related to Although the HO-1 and P450 systems are oxidative stress, including many xenobiotics, such interconnected due to their common electron donor, as aspirin, statins, niacin, etc.
    [Show full text]
  • Lecture 2 Nitric Oxide Synthase and Heme Oxygenase Knockout Mice Ð What Have We Learned?
    International Journal of Impotence Research (2000) 12, Suppl 3, S42±S44 ß 2000 Macmillan Publishers Ltd All rights reserved 0955-9930/00 $15.00 www.nature.com/ijir Lecture 2 Nitric oxide synthase and heme oxygenase knockout mice Ð what have we learned? AL Burnett1* 1Department of Urology, The Johns Hopkins University School of Medicine and The James Buchanan Brady Urological Institute, The Johns Hopkins Hospital, Baltimore, MD 21287, USA The seemingly unthinkable involvement of gaseous transgenic technology or as a basic means to ensure molecules in basic biochemical mechanisms of sexual reproducibility of species. Given these concerns, do physiology only a few years ago seems an almost these mutant animals possibly yield useful informa- indisputable concept within this research ®eld today. tion regarding sexual function? The answer is that Major advances have occurred in the scienti®c under- they do. Early and ongoing investigation of these standing of penile erection and ejaculation, with animals has been informative with results suggest- experimental evidence amply supporting the roles of ing standard and apparently compensatory mechan- nitric oxide (NO) and carbon monoxide (CO) in these isms in¯uencing sexual function. This brief article sexual functions. NO has now been well characterized summarizes research ®ndings associated with the as a major peripheral mediator of penile erection, sexual function of transgenic mice with deleted released by a neurological stimulus upon its synthesis NOS and HO-2 genes, which clari®es roles of these involving neuronal NO synthase (NOS) contained in genes and their chemical products in mammalian the autonomic innervation of the penis and endothe- sexual physiology.
    [Show full text]